홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
VRCA
#4010
Verrica Pharmaceuticals Inc. Common Stock
5.720
0
USD
+1.78%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.78%
월간 변동
-6.08%
6달 변화
-4.98%
년간 변동율
-4.98%
이전 종가
5.620
0
Open
5.720
0
Bid
Ask
Low
5.720
0
High
5.720
0
양
25
마켓
주식
헬스케어
VRCA
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
2.54 M
2.75 M
4.19 M
4.24 M
9.18 M
17.18 M
—
Valuation ratios
Enterprise value
319.03 M
278.02 M
86.26 M
263.43 M
49.8 M
113.19 M
255.21 M
Price to earnings ratio
—
—
-4
-4.6
-0.47
-4.95
-7.55
Price to sales ratio
—
—
10.89
60.26
4.79
2.49
11.43
Price to cash flow ratio
—
—
-5.28
-8
-0.6
-5.02
-7.16
Price to book ratio
—
—
2.46
15.62
-3.68
3.58
2.28
EBITDA 비율에 대한 기업 가치
—
-10.4
-4.16
-3.34
-0.27
-9.23
-11.22
Profitability ratios
Return on assets %
-0.58
-0.44
-0.55
-0.82
-1.41
-0.38
-0.4
Return on equity %
-1.29
-1.08
-0.61
-3.39
7.77
-0.72
0.2
Return on invested capital %
-259.12
-209.79
-295.27
-2 367.24
-972.74
-172.89
—
Gross margin %
—
100
100
90.24
65.64
98.59
374.89
Operating margin %
—
-257.57
-235.78
-1 283.35
-871.25
-34.25
-354.42
EBITDA margin %
—
-254.94
-229.52
-1 282.38
-892.92
-34.29
-371.59
Net margin %
—
-292.33
-271.11
-1 307.47
-1 012.15
-50.27
-442.15
Liquidity ratios
Quick ratio
—
—
—
4.49
1.68
2.45
6.06
Current ratio
1.71
1.61
11.31
4.55
1.76
2.59
6.44
Inventory turnover
—
—
—
—
—
0.21
—
Asset turnover
—
0.16
0.14
0.08
0.11
0.7
0.86
Solvency ratios
Debt to assets ratio
0.5
0.52
—
0.54
0.59
0.01
1.88
Debt to equity ratio
1.12
1.28
—
2.23
-3.23
0.02
-4.27
Long term debt to total assets ratio
0.47
0.5
—
0.53
0.57
0
1.82
Long term debt to total equity ratio
1.06
1.23
—
2.17
-3.14
0
-4.17
Per share metrics
Operating cash flow per share
—
—
-5.46
-8.51
-11.76
-1.65
-1.81
EBIT per share
—
—
-6.23
-14.61
-13.23
-1.19
-1.33
EBITDA per share
—
—
-6.07
-14.49
-13.04
-1.15
-1.28
Total debt per share
—
—
—
9.73
6.15
0.05
8.09
Cash per share
—
—
10.03
15.34
1.93
2.83
7.73
Net current asset value per share
—
—
11.45
17.1
9.88
3.99
15.85
Tangible book value per share
—
—
11.72
4.36
-1.9
2.32
-3.27
Working capital per share
—
—
10.44
13.34
4.28
2.45
5.09
Book value per share
—
—
11.72
4.36
-1.9
2.32
-3.27
뉴스
Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript
베리카 파마슈티컬 주가, 파트너사의 일본 내 YCANTH 출시 후 상승
Verrica Pharmaceuticals stock rises after partner launches YCANTH in Japan
Verrica’s partner launches molluscum treatment in Japan
Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why
New Strong Buy Stocks for February 2nd
How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%
베리카 파마슈티컬스, TD Cowen ’매수’ 등급 재확인에 상승세
Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating
Verrica doses first patient in phase 3 trial for common wart treatment
베리카 파마슈티컬스, 이사회에 Charles Frantzreb 임명 및 주식 부여 승인
Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants